gibbs trial survival data

gibbs trial survival data

Cut Progression Risk 50% With Prostate Cancer Data

Cut Progression Risk 50% With Prostate Cancer Data In the Gibbs trial, 90% of participants achieved five-year overall survival, showing a dramatic lift over standard regimens. This figure answers the core question: the data suggest a realistic pathway to cut progression risk by half when the right patients receive the